Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the โ€œCompanyโ€ or โ€œOption Care Healthโ€) (Nasdaq: OPCH), the nationโ€™s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended Septemberย 30, 2025.

Third Quarter 2025 Financial Highlights

(Year-over-year comparisons unless otherwise noted)

  • Net revenue of $1,435.0 million, up 12.2%
  • Gross profit of $272.9 million, up 6.3%
  • Net income of $51.8 million, down 3.8%
  • GAAP diluted earnings per share of $0.32, up 3.2%
  • Adjusted EBITDA of $119.5 million, up 3.4%
  • Adjusted diluted earnings per share of $0.45, up 9.8%
  • YTD cash provided by operating activities of $222.6 million
  • Repurchased $62.5 million of stock in the quarter
  • Term loan expanded $49.6 million, and interest rate reduced

John C. Rademacher, Chief Executive Officer, commented, โ€œThe Option Care Health team delivered another strong quarter with balanced growth across the portfolio. Iโ€™d like to thank our team for their extraordinary execution and continued dedication to providing access to quality care to more patients. We are well positioned for success as we continue to navigate a dynamic regulatory environment, changing competitive landscapes, and our evolving portfolio of therapies while always keeping the patient at the center of everything we do.โ€

Updated Full Year 2025 Financial Guidance

For the full year 2025, Option Care Health now expects to generate:

  • Net revenue of $5.60ย billion to $5.65ย billion
  • Adjusted diluted earnings per share of $1.68 to $1.72
  • Adjusted EBITDA of $468ย million to $473ย million
  • Cash flow from operations of at least $320ย million
  • Effective tax rate of 25% to 27%
  • Net interest expense of approximately $55ย million to $57ย million

Conference Call

Option Care Health will host a conference call to discuss its results on Thursday, Octoberย 30, 2025, at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available at the same web link for 90 days after the call.

About Option Care Health

Option Care Health is the nationโ€™s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

Investor Contact

Stephen Shulstein
Vice President, Investor Relations
stephen.shulstein@optioncare.com
ย 

Forward-Looking Statements - Safe Harbor

This press release may contain โ€œforward-looking statementsโ€ within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: โ€œanticipate,โ€ โ€œintend,โ€ โ€œplan,โ€ โ€œbelieve,โ€ โ€œproject,โ€ โ€œestimate,โ€ โ€œexpect,โ€ โ€œmay,โ€ โ€œshould,โ€ โ€œwillโ€ and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our periodic reports as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Note Regarding Use of Non-GAAP Financial Measures

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted diluted earnings per share ("Adjusted EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, earnings per share, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Companyโ€™s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted diluted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain longโ€‘lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Healthโ€™s business operations and facilitate comparisons to the Companyโ€™s historical operating results. We have not reconciled Adjusted EBITDA or Adjusted diluted earnings per share guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each adjusted measure to the most comparable GAAP financial measure are set forth below.

ย ย Schedule 1

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)(UNAUDITED)

ย 


ย September 30, 2025ย December 31, 2024
ASSETSย ย ย 
CURRENT ASSETS:ย ย ย 
Cash and cash equivalents$309,822ย $412,565
Accounts receivable, netย 474,500ย ย 409,733
Inventoriesย 415,723ย ย 388,131
Prepaid expenses and other current assetsย 82,721ย ย 112,198
Total current assetsย 1,282,766ย ย 1,322,627
ย ย ย ย 
NONCURRENT ASSETS:ย ย ย 
Property and equipment, netย 134,298ย ย 127,367
Intangible assets, netย 22,732ย ย 16,993
Referral sources, netย 295,716ย ย 284,017
Goodwillย 1,606,646ย ย 1,540,246
Other noncurrent assetsย 137,687ย ย 130,493
Total noncurrent assetsย 2,197,079ย ย 2,099,116
TOTAL ASSETS$3,479,845ย $3,421,743
ย ย ย ย 
LIABILITIES AND STOCKHOLDERSโ€™ EQUITYย ย ย 
CURRENT LIABILITIES:ย ย ย 
Accounts payable$627,867ย $610,779
Other current liabilitiesย 196,039ย ย 169,367
Total current liabilitiesย 823,906ย ย 780,146
ย ย ย ย 
NONCURRENT LIABILITIES:ย ย ย 
Long-term debt, net of discount, deferred financing costs and current portionย 1,155,056ย ย 1,104,641
Other noncurrent liabilitiesย 142,224ย ย 132,718
Total noncurrent liabilitiesย 1,297,280ย ย 1,237,359
Total liabilitiesย 2,121,186ย ย 2,017,505
ย ย ย ย 
STOCKHOLDERSโ€™ EQUITYย 1,358,659ย ย 1,404,238
TOTAL LIABILITIES AND STOCKHOLDERSโ€™ EQUITY$3,479,845ย $3,421,743
ย ย ย ย ย ย 

Schedule 2

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)

ย 


ย Three Months Ended Septemberย 30,ย Nine Months Ended Septemberย 30,
ย ย 2025ย ย ย 2024ย ย ย 2025ย ย ย 2024ย 
NET REVENUE$1,435,016ย ย $1,278,546ย ย $4,184,073ย ย $3,651,784ย 
COST OF REVENUEย 1,162,114ย ย ย 1,021,797ย ย ย 3,379,076ย ย ย 2,907,170ย 
GROSS PROFITย 272,902ย ย ย 256,749ย ย ย 804,997ย ย ย 744,614ย 
ย ย ย ย ย ย ย ย 
OPERATING COSTS AND EXPENSES:ย ย ย ย ย ย ย 
Selling, general and administrative expensesย 172,104ย ย ย 156,999ย ย ย 510,314ย ย ย 465,524ย 
Depreciation and amortization expenseย 16,291ย ย ย 14,659ย ย ย 48,278ย ย ย 44,294ย 
Total operating expensesย 188,395ย ย ย 171,658ย ย ย 558,592ย ย ย 509,818ย 
OPERATING INCOMEย 84,507ย ย ย 85,091ย ย ย 246,405ย ย ย 234,796ย 
ย ย ย ย ย ย ย ย 
OTHER INCOME (EXPENSE):ย ย ย ย ย ย ย 
Interest expense, netย (14,146)ย ย (12,345)ย ย (41,824)ย ย (38,150)
Other, netย (1,394)ย ย 808ย ย ย (3,197)ย ย 5,904ย 
Total other (expense) incomeย (15,540)ย ย (11,537)ย ย (45,021)ย ย (32,246)
ย ย ย ย ย ย ย ย 
INCOME BEFORE INCOME TAXESย 68,967ย ย ย 73,554ย ย ย 201,384ย ย ย 202,550ย 
INCOME TAX EXPENSEย 17,151ย ย ย 19,698ย ย ย 52,303ย ย ย 50,860ย 
NET INCOME$51,816ย ย $53,856ย ย $149,081ย ย $151,690ย 
ย ย ย ย ย ย ย ย 
Earnings per share, basic$0.32ย ย $0.32ย ย $0.91ย ย $0.88ย 
Earnings per share, diluted$0.32ย ย $0.31ย ย $0.91ย ย $0.87ย 
ย ย ย ย ย ย ย ย 
Weighted average common shares outstanding, basicย 161,829ย ย ย 170,636ย ย ย 163,393ย ย ย 172,490ย 
Weighted average common shares outstanding, dilutedย 163,086ย ย ย 171,941ย ย ย 164,602ย ย ย 173,848ย 
ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย ย 

Schedule 3

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)(UNAUDITED)

ย 


ย Nine Months Ended Septemberย 30,
ย ย 2025ย ย ย 2024ย 
CASH FLOWS FROM OPERATING ACTIVITIES:ย ย ย 
Net income$149,081ย ย $151,690ย 
Adjustments to reconcile net income to net cash provided by operations:ย ย ย 
Depreciation and amortization expenseย 50,374ย ย ย 46,029ย 
Other adjustmentsย 57,401ย ย ย 54,926ย 
Changes in operating assets and liabilities:ย ย ย 
Accounts receivable, netย (55,430)ย ย (51,293)
Inventoriesย (24,899)ย ย (36,595)
Prepaid expenses and other current assetsย 24,694ย ย ย (3,175)
Accounts payableย 10,224ย ย ย 164,754ย 
Accrued compensation and employee benefitsย 8,338ย ย ย (31,673)
Otherย 2,773ย ย ย (7,393)
Net cash provided by operating activitiesย 222,556ย ย ย 287,270ย 
ย ย ย ย 
CASH FLOWS FROM INVESTING ACTIVITIES:ย ย ย 
Acquisition of property and equipmentย (27,661)ย ย (25,266)
Business acquisitions, net of cash acquiredย (117,247)ย ย โ€”ย 
Other investing activitiesย (2,529)ย ย โ€”ย 
Net cash used in investing activitiesย (147,437)ย ย (25,266)
ย ย ย ย 
CASH FLOWS FROM FINANCING ACTIVITIES:ย ย ย 
Purchase of company stock and related excise taxesย (214,887)ย ย (160,122)
Proceeds from issuance of debtย 229,472ย ย ย 49,959ย 
Retirement of debt obligationsย (180,239)ย ย โ€”ย 
Other financing activitiesย (12,208)ย ย (12,664)
Net cash used in financing activitiesย (177,862)ย ย (122,827)
ย ย ย ย 
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTSย (102,743)ย ย 139,177ย 
Cash and cash equivalents - beginning of the periodย 412,565ย ย ย 343,849ย 
CASH AND CASH EQUIVALENTS - END OF PERIOD$309,822ย ย $483,026ย 
ย ย ย ย ย ย ย ย 

Schedule 4

OPTION CARE HEALTH, INC.
QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)

ย 


ย Three Months Ended Septemberย 30,ย Nine Months Ended Septemberย 30,
ย ย 2025ย ย ย 2024ย ย ย 2025ย ย ย 2024ย 
Net income$51,816ย ย $53,856ย ย $149,081ย ย $151,690ย 
Interest expense, netย 14,146ย ย ย 12,345ย ย ย 41,824ย ย ย 38,150ย 
Income tax expenseย 17,151ย ย ย 19,698ย ย ย 52,303ย ย ย 50,860ย 
Depreciation and amortization expenseย 17,048ย ย ย 15,227ย ย ย 50,374ย ย ย 46,029ย 
EBITDAย 100,161ย ย ย 101,126ย ย ย 293,582ย ย ย 286,729ย 
ย ย ย ย ย ย ย ย 
EBITDA adjustmentsย ย ย ย ย ย ย 
Stock-based incentive compensation expenseย 11,125ย ย ย 10,407ย ย ย 30,638ย ย ย 27,620ย 
Loss on extinguishment of debtย 4,744ย ย ย โ€”ย ย ย 4,744ย ย ย 377ย 
Restructuring, acquisition, integration and otherย 3,468ย ย ย 4,050ย ย ย 16,318ย ย ย 7,504ย 
Adjusted EBITDA$119,498ย ย $115,583ย ย $345,282ย ย $322,230ย 
ย ย ย ย ย ย ย ย 
Net income$51,816ย ย $53,856ย ย $149,081ย ย $151,690ย 
Intangible asset amortization expenseย 9,269ย ย ย 8,596ย ย ย 27,663ย ย ย 25,809ย 
Stock-based incentive compensation expenseย 11,125ย ย ย 10,407ย ย ย 30,638ย ย ย 27,620ย 
Loss on extinguishment of debt (2)ย 4,744ย ย ย โ€”ย ย ย 4,744ย ย ย โ€”ย 
Restructuring, acquisition, integration and otherย 3,468ย ย ย 4,050ย ย ย 16,318ย ย ย 7,504ย 
Total pre-tax adjustmentsย 28,606ย ย ย 23,053ย ย ย 79,363ย ย ย 60,933ย 
Tax adjustments (1)ย (7,183)ย ย (6,178)ย ย (20,634)ย ย (15,294)
Adjusted net income$73,239ย ย $70,731ย ย $207,810ย ย $197,329ย 
ย ย ย ย ย ย ย ย 
Earnings per share, diluted$0.32ย ย $0.31ย ย $0.91ย ย $0.87ย 
Adjusted earnings per share, diluted$0.45ย ย $0.41ย ย $1.26ย ย $1.14ย 
Weighted average common shares outstanding, dilutedย 163,086ย ย ย 171,941ย ย ย 164,602ย ย ย 173,848ย 

(1) Tax adjustments for the three and nine months ended September 30, 2025 and 2024 include the estimated income tax effect on non-GAAP adjustments based on the effective tax rate

(2) Beginning with the three months ended September 30, 2025, adjusted net income excludes loss on extinguishment of debt on a prospective basis, which has been immaterial in prior periods.


Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.00 (0.00%)
AAPL  286.19
+0.00 (0.00%)
AMD  215.24
+0.00 (0.00%)
BAC  53.19
+0.00 (0.00%)
GOOG  316.02
+0.00 (0.00%)
META  647.10
+0.00 (0.00%)
MSFT  490.00
+0.00 (0.00%)
NVDA  181.46
+0.00 (0.00%)
ORCL  201.10
+0.00 (0.00%)
TSLA  429.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gift this article